Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation
Taaning, E.; Jacobsen, N.
Transplantation Proceedings 26(3): 1826
1994
ISSN/ISBN: 0041-1345 PMID: 8030157 Document Number: 427584
Document emailed within 1 workday
Related Documents
Davies, S.M.; Weisdorf, D.J.; Haake, R.J.; Kersey, J.H.; McGlave, P.B.; Ramsay, N.K.; Blazar, B.R. 1994: Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation Bone Marrow Transplantation 14(1): 73-77de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Vannucchi, A.M.; Bosi, A.; Laszlo, D.; Guidi, S.; Saccardi, R.; Rossi-Ferrini, P. 1995: Treatment of a delayed graft failure after allogeneic bone marrow transplantation with IL-3 and GM-CSF Haematologica 80(4): 341-343
Li, V.; Molina, L.; Michallet, M.; Hostein, J. 1992: Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion Gastroenterologie Clinique et Biologique 16(1): 29-36
Yasumizu, R.; Hiai, H.; Sugiura, K.; Oyaizu, N.; Fan, H.X.; Ohnishi, Y.; Iwai, H.; Inaba, M.; Kakinuma, M.; Onoe, K. 1988: Development of donor-derived thymic lymphomas after allogeneic bone marrow transplantation in AKR/J mice Journal of Immunology 141(6): 2181-2186
Mangan, K.F. 1987: Immunologic control of hemopoiesis: implications for quality of the graft after allogeneic bone marrow transplantation Transplantation Proceedings 19(6 Suppl 7: 23-28
Sullivan, K.M.; Siadak, M.F.; Witherspoon, R.P. 1990: Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation Transplantation Proceedings 22(3): 1336-1338
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Brok, H.P.; Heidt, P.J.; van der Meide, P.H.; Zurcher, C.; Vossen, J.M. 1993: Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice Journal of Immunology 151(11): 6451-6459
Tong, J.; Viale, M.; Bacigalupo, A.; Podestà, M.; Sogno, G.; Tedone, E.; Marmont, A.M. 1992: Cytokine serum levels and acute graft versus host disease after allogeneic bone marrow transplantation Haematologica 77(4): 365-366
Jeannet, M.; Vaucher, A.; Gervasoni, C. 1972: Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation Schweizerische Medizinische Wochenschrift 102(44): 1598-1600
Poros, A.; Petrányi, J.; Harsányi, V.; Mód, A.; Bernyäk, J.; Hollán, Z. 1989: Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary) Folia Haematologica 116(3-4): 409-411
Cooper, M.H.; Markus, P.M.; Cai, X.; Starzl, T.E.; Fung, J.J. 1991: Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506 Transplantation Proceedings 23(6): 3238-3239
Smyth, L.A.; Witt, C.S.; Christiansen, F.T.; Herrmann, R.P.; Hollingsworth, P.N.; Townend, D.C.; Edward, E.; Dawkins, R.L. 1993: The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation Bone Marrow Transplantation 12(4): 351-355
Du, B.; Li, D-peng.; Xu, K-lin.; Pan, X-ying. 2005: Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice Chinese Medical Journal 118(6): 474-479
Nevo, S.; Enger, C.; Swan, V.; Wojno, K.J.; Fuller, A.K.; Altomonte, V.; Braine, H.G.; Noga, S.J.; Vogelsang, G.B. 1999: Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival Transplantation 67(5): 681-689
Michallet, M.; Corront, B.; Hollard, D.; Gratwohl, A.; Domingo, A.; Burnett, S. 1988: Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (8 cases) Nouvelle Revue Francaise d'Hematologie 30(5-6): 467-470
Mrsić, M.; Labar, B.; Bogdanić, V.; Nemet, D.; Pavletić, Z.; Plavsić, F.; Dobrić, I.; Kastelan, A.; Marusić, M.; Zupancić-Salek, S. 1989: Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias Bone Marrow Transplantation 4(Suppl): 95-96
Bykova, T.A.; Kozlov, A.V.; Stancheva, N.V.; Semënova, E.V.; Kulagina, I.I.; Bondarenko, S.N.; Vavilov, V.N.; Morozova, E.V.; Zubarovskaia, L.S.; Afanas'ev, B.V. 2013: Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation Terapevticheskii Arkhiv 85(8): 60-68
Lenz, M.; Haen, M. 1991: Pneumatosis cystoides intestinalis. a possible complication of acute intestinal graft versus host reaction following allogeneic bone marrow transplantation Rontgenpraxis; Zeitschrift für Radiologische Technik 44(11): 336-338